# A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Study · id `cardio:ct-nct03751657` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03751657](<https://clinicaltrials.gov/study/NCT03751657>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03751657

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 247 participants.

## Technical summary

Registry record NCT03751657. Randomized; quadruple masking; primary purpose treatment. Start 2018-11-29 (actual); primary completion 2019-12-16 (actual). Results posted on 2021-02-01.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 247 participants (enrolled count; ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Started: 2018-11-29 (actual) (ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Primary completion: 2019-12-16 (actual) (ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Completion: 2020-01-17 (actual) (ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Results first posted: 2021-02-01 (ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Countries: United States; Canada; Czechia; Greece; Poland; Slovakia; Slovenia (ClinicalTrials.gov record NCT03751657, source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03751657-2021-04-02`, retrieved 2026-11-18)

## The registry's words

- Brief title: A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.
- Condition: Diabetes Mellitus, Type 2
- Intervention (Drug): Insulin icodec
- Intervention (Drug): Placebo (insulin 287)
- Intervention (Drug): Metformin
- Intervention (Drug): Dipeptidyl peptidase-4 inhibitors
- Intervention (Drug): Insulin glargine
- Intervention (Drug): Placebo (insulin glargine)
- Lead sponsor: Novo Nordisk A/S
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Novo Nordisk (`cardio:novo-nordisk`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment (`cardio:pubmed-32960514`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8f0e8b9d21d697619fb1e305e30319294d11346bef4b7d5f9ef9212e5c9bee5b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
